Diogo’s main research interest focus on the study of microglia cells and neuroinflammation, the mechanisms of neuroinflammation and novel approaches to modulate microglia, especially in the context of neurodegenerative diseases, like Parkinson’s Disease. Diogo Carregosa concluded his PhD in Biomedicine at NOVA Medical School, following a MSc in Biochemistry for Health in 2018 and a BSc in Biochemistry in 2016.
Diogo has been working with microglia cells since 2017. Diogo has experience in the synthesis and characterization of small phenolics, natural and synthetic, and its characterization; in vitro culture of immortalized and primary microglia cells; mice models of neuroinflammation and Parkinson’s Disease; animal behavior analysis; quantification of inflammatory markers in plasma and tissue; as well as, genomic, proteomic, and metabolomic techniques.
Diogo Carregosa has 10 publications in scientific journals, 3 book chapters, and has participated in several international conferences. He has also participated in two COST Actions related to neurodegenerative diseases and Parkinson’s disease. From his work, Diogo has a patent application for the use of small phenolics to treat Neurodegenerative Diseases.